Filing Details

Accession Number:
0000950170-24-012838
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-08 16:37:35
Reporting Period:
2024-02-06
Accepted Time:
2024-02-08 16:37:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1572616 Fractyl Health Inc. GUTS Surgical & Medical Instruments & Apparatus (3841) 273553477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1875614 Ajay Royan C/O Fractyl Health, Inc.
17 Hartwell Avenue
Lexington MA 02421
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-06 5,160,301 $0.00 5,160,301 No 4 C Indirect See footnote
Common Stock Acquisiton 2024-02-06 918,567 $0.00 918,567 No 4 C Indirect See footnote
Common Stock Acquisiton 2024-02-06 333,333 $15.00 1,251,900 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C-1 Preferred Stock Disposition 2024-02-06 4,025,764 $0.00 1,875,938 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2024-02-06 6,502,796 $0.00 3,030,193 $0.00
Common Stock Series D Preferred Stock Disposition 2024-02-06 545,450 $0.00 254,170 $0.00
Common Stock Series E Preferred Stock Disposition 2024-02-06 373,021 $0.00 173,821 $0.00
Common Stock Series F Preferred Stock Disposition 2024-02-06 1,598,225 $0.00 744,746 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock.
  2. Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.
  3. Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any.